VIDAZA

Powder for suspension for injection, 100mg
RxActive license

Active substance (INN)

azacitidine

Pharmaceutical form

Pharmaceutical formPowder for suspension for injection
Strength100mg
PackagingUkupno 1 bočica staklena sa praškom za suspenziju za injekciju u kartonskoj kutiji
ManufacturerBaxter Oncology GmbH, Germany
Therapeutic groupAntineoplastic and immunomodulating agents (L01BC07)
Marketing authorization holderAMICUS PHARMA DOO PODGORICA
Authorization dateJune 28, 2024

Analogs in Montenegro

4

Other medicines with the same active substance

AZACITIDIN HFRx
Powder for suspension for injection, 25mg/mlStada Arzneimittel AG
AZACITIDIN HFRx
Powder for suspension for injection, 25mg/mlStada Arzneimittel AG
AZACITIDIN STADARx
Powder for suspension for injection, 25mg/mlStada Arzneimittel AG
AZACITIDINE ACCORDRestricted
Powder for suspension for injection, 25mg/mlAccord Healthcare Polska Sp. z o.o. Magazyn Importera
Source: CInMED register